/Sponsor / Executive Profile

Jurgen van de Vyver

Executive

Aggregate Capital Deployment Matrix

Active/Searching: $862M (68.1%)

Professional Biography

Jurgen van de Vyver is a seasoned financial executive with extensive experience in the SPAC sector. He has served as the Chief Financial Officer of Launch One Acquisition Corp. since its inception, demonstrating a strong commitment to the financial stewardship of the organization. In addition to his role at Launch One Acquisition Corp., Jurgen van de Vyver has also held the position of Chief Financial Officer for NCAC, where he has been instrumental since the company's founding. His responsibilities encompass overseeing financial operations and ensuring compliance with regulatory requirements. With a proven track record as a Principal Financial and Accounting Officer, Jurgen van de Vyver brings a wealth of expertise to his roles, contributing to the successful execution of multiple SPAC transactions. His leadership and strategic insight have been pivotal in navigating the complexities of the financial landscape within the SPAC industry.

Total Capital Deployed

$1,266,000,000

Active / Searching Capital:
$862,000,000

Transaction Volume

7 Transactions

Time-to-Liquidity (Months)

-

Merger Completion Rate

57.1%

Professional Network Intelligence

Frequent Associates

Top Sectors

  • Biotechnology2 Deals

Syndicate Deal History

TickerCompanyStatusTrustPriceWarrantIPO DateTime LeftDeal ValueSectorBookrunner
LPCV
Launchpad Cadenza Acquisition Corp I
searching
200.0M
$10.00
1/3Nov 2025
19mo
-GeneralCantor Fitzgerald & Co.
LPSL
Launchpad Streetlight Acquisition Corp
searching
200.0M
$10.00
1/2Nov 2025
19mo
-GeneralCantor Fitzgerald & Co.
WENN
Wen Acquisition Corp
searching
261.0M
$10.00
1/2Apr 2025
13mo
-GeneralCantor Fitzgerald & Co.
LPBB
Launch Two Acquisition Corp.
searching
201.0M
$10.00
1/2Jul 2024
4mo
-GeneralCantor Fitzgerald & Co.
LPAA
Launch One Acquisition Corp.
closed
200.0M
$10.00
1/2Jun 2024Done-GeneralCantor Fitzgerald & Co.
PBM
Psyence Biomed II Corp.
closed
-
$10.00
-Feb 2024Done
50.0M
BiotechnologyCantor Fitzgerald & Co.
NCAC
Newcourt Acquisition Corp
closed
204.0M
$10.00
1/2Mar 2021Done
50.0M
BiotechnologyCantor Fitzgerald & Co.